 |
Herpes simplex 1 virus-thymidine kinase and truncated low affinity nerve growth factor receptor transfected donor lymphocytes |
|---|---|
| Trade Name | Zalmoxis |
| Orphan Indication | Adjunctive treatment in hematopoietic cell transplantation |
| EU Market Approval | EU |
| EU Designation Date | 2003-10-20 00:00:00 |
| Sponsor | MolMed S.p.A. |
